ALAMAR BIOSCIENCES, INC.
NULISA, an ultra-sensitive immunoassay technology for protein biomarker detection in blood plasma enabling early cancer detection
- Sector
- Biotech
- Total capital
- $4.4M
- Federal grants
- $322K
- 1 award · 2020
- Rank in peer group#25 of 26
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $4.1M
- 10 awards · Health and Human S, Veterans Affairs
- Rank in Biotech#95 of 4373
- Granted patents
- 2
- 19 pending · first 2024
- Rank in peer group#4 of 26
Capital timeline
Latest events
- Federal contractHealth and Human S · Preventive Maintenance And Repair Service - Argo System Proteomics Equipment.$25K
- Federal contractHealth and Human S · Alamar Biosciences, INC.:1334504 [25-004811] Purchase Three (3) 120 Cns Kits To Be Measured On The Alamar Nulisa Platform Which Contains Over 120 Disease Markers.$30K
- Federal contractVeterans Affairs · Research$510K
- Federal contractHealth and Human S · Nulisaseq Mouse Panel. Proteomic Mouse Panel Analysis For The Investigation Of Potential Biomarkers.$100K
- Federal contractHealth and Human S · Alamar Biosciences, INC.:1334504 [25-004678]$20K
- Federal contractHealth and Human S · Alamar Nulisaseq Inflammation Panel 250 Reagents$324K
- Federal contractHealth and Human S · Single-plex Nulisapcr Absolute Quantification Assay Of HDGFL2 In Plasma Samples$57K
Show 4 earlier federal awards
- Federal contractHealth and Human S · Argo Ht Instrument And Nulisaseq Cns Disease Panel$2.8M
- Federal contractHealth and Human S · Nulisaseq Cns Disease Panel-services$247K
- Federal contractHealth and Human S · Laboratory And Testing Services For Nulisaseq Cns Disease Panel-service$18K
- Federal grantHealth and Human S · Phase I · Ultrasensitive detection of protein targets in plasma for early detection of cancer$322K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 26 peers
Line = medianBiotech · Instrument
- Federal grantsBelow median
- Granted patents#4 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 21- PendingFully Automatic Instrument System for Biochemical AssaysUSPTOApplication 19183520
- PendingFully Automatic Instrument System for Biochemical AssaysUSPTOApplication 19183502
- PendingBinder Molecules With High Affinity And/ Or Specificity And Methods Of Making And Use ThereofUSPTOApplication 18268936
Show all 21 patent records
- Fully Automatic Instrument System for Biochemical AssaysNov 6, 2025 · Application 19183520Pending
- Fully Automatic Instrument System for Biochemical AssaysOct 2, 2025 · Application 19183502Pending
- Binder Molecules With High Affinity And/ Or Specificity And Methods Of Making And Use ThereofJun 19, 2025 · Application 18268936Pending
- Nucleic Acid Linked Immune-sandwich Assay (nulisa)May 1, 2025 · Application 18764021Pending
- Nucleic Acid Linked Immune-sandwich Assay (nulisa)Jan 7, 2025 · US 12,188,929Granted
- Nucleic Acid Linked Immune-sandwich Assay (nulisa)Oct 1, 2024 · US 12,105,084Granted
- Nucleic Acid Linked Immune-sandwich Assay (nulisa)Dec 8, 2022 · Application 17830184Pending
- Reduction Of Non-cognate Signal In Multiplex Proximity Ligation AssaysApplication 63601038Pending
- Use Of Autoinhibition Standard Curves In Proximity AssaysApplication 63601034Pending
- Use Of Autoinhibition Standard Curves In Proximity AssaysApplication PCTUS2024056773Pending
- Fully automatic instrument system for biochemical assaysApplication 63501355Pending
- Binder Molecules With High Affinity And/ Or Specificity And Methods Of Making And Use ThereofApplication PCTUS2021073173Pending
- Nucleic Acid Linked Immune-sandwich Assay (nulisa)Application 63196204Pending
- Co-binders With High Affinity And Methods Of Use ThereofApplication 63133005Pending
- Co-binders With High Affinity And Methods Of Use ThereofApplication 63133020Pending
- Nucleic Acid Linked Immune-sandwich Assay (nulisa)Application PCTUS2020062791Pending
- Reduction Of Non-cognate Signal In Multiplex Proximity Ligation AssaysApplication PCTUS2024056774Pending
- Nucleic Acid Linked Immune-sandwich Assay (nulisa)Application 62943135Pending
- Molecular Barcode Set And Use Thereof In Multiplex Proximity Detection AssaysApplication PCTUS2024056772Pending
- A Fully Automatic Instrument System For Biochemical AssaysApplication PCTUS2024028888Pending
- Molecular Barcode Set And Use Thereof In Multiplex Proximity Detection AssaysApplication 63601031Pending
Related companies, and why
- A&G PHARMACEUTICAL, INC.Similar federal contract value in Biotech · $4.2M in contracts
- UNIVERSAL STABILIZATION TECHNOLOGIES, INC.Similar federal contract value in Biotech · $4.2M in contracts
- Tissue Genesis, IncSimilar federal contract value in Biotech · $4.2M in contracts
- CAIRN BIOSCIENCES INCSimilar federal contract value in Biotech · $4M in contracts
- CELDARA MEDICAL, LLCSimilar federal contract value in Biotech · $4M in contracts
- BioQ Pharma IncSimilar federal contract value in Biotech · $4M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .